Description
This peptide is an analog of a sequence of HIV-1 for which cytotoxic T lymphocytes may bind.
| Product Unit Size | Cost | Quantity | Stock |
|---|
This peptide is an analog of a sequence of HIV-1 for which cytotoxic T lymphocytes may bind.
| Purity | ≥98% |
|---|---|
| Formula | C108H167N27O29 |
| Formula Wt. | 2307.67 |
| Synonym | HIV Endonuclease Antigenic Site; HIV Endonuclease. |
| Solubility | Soluble in water (2 mg/mL), acetonitrile. |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Rahman MA, Kuse N, Murakoshi H, et al. Raltegravir and elvitegravir-resistance mutation E92Q affects HLA-B*40:02-restricted HIV-1-specific CTL recognition. Microbes Infect. 2014 May;16(5):434-8. PMID: 24657622.
Triazole; demethylation inhibitor.
SK K+ channel blocker, EGFR inhibitor.
Polymixin, antimicrobial peptide, induces forma...
Glucocorticoid
5-Nitroimidazole derivative; genotoxic.
BRG1/BRM ATPase inhibitor
RF-amide peptide; potential GPR147 agonist, pot...
β-lactam; penicillin binding protein inhibitor...
Triterpene aglycone found in Radix Astragali; t...
ATM and ATR inhibitor.
Calpain I/II inhibitor.
ALK inhibitor.
BHA derivative, antioxidative food and cosmetic...
Peptide, derivative of AT II, involved in vasoc...
Thienylbutyl ITC analog.